Reticine Pharmaids Limited, a active public limited company, was established on 30 November 2005 in Chandigarh, Chandigarh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U00304CH2005PLC029266. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Formerly known as Navdeep Bioceuticals Limited. It upholds a compliant status. Its leadership includes Yogesh Gupta (Director), Ayush Gupta (Director), Shivam Gupta (Director). Past directors included Virender Singhal, Naresh Kumar, Sanjiv Gupta. It holds ₹2.16 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 2003, Milk Colony Sector 14 (W), Dhanas, Chandigarh, Chandigarh, 160014.
U00304CH2005PLC029266
029266
30 November 2005
₹0.50 M
₹0.50 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Reticine Pharmaids Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yogesh Gupta | Director | 27 Jul 2018 | Current |
| Ayush Gupta | Director | 21 Nov 2018 | Current |
| Shivam Gupta | Director | 27 Jul 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Sep 2018 | Past |
| Pramod Abcsdd | Director | 03 Nov 2010 | Past |
| Pramod Abcsdd | Director | 17 Sep 2018 | Past |
| Pramod Abcsdd | Director | 05 Nov 2019 | Past |
| Pramod Abcsdd | Additional Director | 05 Dec 2017 | Past |
| Pramod Abcsdd | Director | 26 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Reticine Pharmaids Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Reticine Pharmaids had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,156,681.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2023 | Hdfc Bank Limited | ₹2.16 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Reticine Pharmaids, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Reticine Pharmaids, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reticine Pharmaids's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Reticine Pharmaids Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Reticine Pharmaids Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 2.16 M with Charge ID 100828810 was registered on 30 Oct 2023. was completed.
Progress on Ayush Gupta was appointed as a Director was appointed as a Director on 21 Nov 2018 & has been associated with this company since 7 years 12 days . was documented.
Yogesh Gupta was appointed as a Director was appointed as a Director on 27 Jul 2018 & has been associated with this company since 7 years 4 months . was recorded as a recent event.
Progress on Shivam Gupta was appointed as a Director was appointed as a Director on 27 Jul 2018 & has been associated with this company since 7 years 4 months . was documented.
The CIN of Reticine Pharmaids Limited is U00304CH2005PLC029266.
Reticine Pharmaids Limited is headquartered at Shop No. 2003, Milk Colony Sector 14 (W), Dhanas, Chandigarh, Chandigarh, 160014.
Reticine Pharmaids Limited was incorporated on 30 November 2005.
The current directors of Reticine Pharmaids Limited are
The primary industry of Reticine Pharmaids Limited is Pharma.
Reticine Pharmaids Limited is unlisted.
The authorized capital of Reticine Pharmaids Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Reticine Pharmaids Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX